Summary
There are widespread disturbances in hepatic and peripheral metabolism in sepsis. Prominent effects include elevated plasma concentrations of aromatic and sulfur-containing amino acids during sepsis, while BCAA are normal or reduced. These alterations probably in part reflect accelerated muscle protein breakdown and hepatic dysfunction. Concomitant with changes in plasma amino acids, altered brain levels of amino acids and neurotransmitters are observed. Increased brain concentrations of the serotoninergic and reduced levels of the catecholaminergic neurotransmitters, along with the occurrence of false neurotransmitters, may be important factors in the pathophysiology of septic encephalopathy. Although the main objective in the treatment of septic patients, of course, is to remove or drain the septic focus, recent studies have shown that administration of BCAA-enriched solutions may be beneficial in the improvement of metabolic derangements and septic encephalopathy.
It should be emphasized that not a great deal of work has been done in this area, and the above results are preliminary and fragmentary. However, they do at least provide a working hypothesis for testing of another form of metabolic encephalopathy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Fischer JE, Baldessarini RJ (1971) False neurotransmitters and hepatic failure. Lancet 2:75
James JH, Jeppsson B, Ziparo V, Fischer JE (1979) Hyperammonemia, plasma amino acid imbalance, and blood-brain amino acid transport: a unified theory of portal-systemic encephalopathy. Lancet 2:772
Baraldi M, Zeneroli ML (1982) Experimental hepatic encephalopathy: changes in the binding of γ-aminobutyric acid. Science 216:427
Roberts E (1984) The γ-aminobutyric acid (GABA) system and hepatic encephalopathy. Hepatology 4:342
Rosen HM, Yoshimura N, Hodgman JM, Fischer JE (1977) Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology 72:483
Freund HR, Ryan JA, Fischer JE, (1978) Amino acid derangements in patients with sepsis: treatment with branched chain amino acid rich infusions. Ann Surg 188:423
James JH, Fischer JE (1981) Encephalopaphy and the bloodbrain barrier. Lancet 2:1420
Jeppsson B, Freund HR, Gimmon Z, James JH, von Meyenfeldt MF, Fischer JE (1981) Blood-brain barrier derangement in sepsis: cause of septic encephalopathy. Am J Surg 141:136
Freund HR, Muggia-Sullam M, LaFrance R, Fischer JE (1984) Brain neurotransmitter derangements during abdominal sepsis and septic encephalopathy in the rat. Surg Forum 35:28
McCullough AJ, Czaja AJ, Jones JD, Go VLW (1981) The nature and prognostic significance of serial amino acid determinations in severe chronic active liver disease. Gastroenterology 81:645
Aulick LH, wilmore DW (1979) Increased peripheral amino acid release following burn injury. Surgery 85:560
Rosenblatt S, Clowes GHA, George BC, Hirsch E, Lindberg B (1983) Exchange of amino acids by muscle and liver in sepsis. Arch Surg 118:167
Freund HR, Atamian S, Holroyde J, Fischer JE (1979) Plasma amino acids as predictors of the severity and outcome of sepsis. Ann Surg 190:571
Fischer JE, Funovics JM, Aguirre A, James JH, Keane JM, Wesdorp RIC, Yoshimura N, Westman T (1975) The role of plasma amino acids in hepatic encephalopathy. Surgery 78:276
Freund HR, Muggia-Sullam M, LaFrance R, Holroyde J, Fischer JE (1985) Regional brain amino acid and neurotransmitter derangements during abdominal sepsis and septic encephalopathy in the rat: the effect of amino acid infusions. Arch Surg (in press)
James JH, Escourrou J, Fischer JE (1978) Blood-brain neutral amino acid transport activity is increased after portacaval anastomosis. Science 200:1395
Herlin PM, James JH, Nachbauer CA, Fischer JE (1983) Effect of total hepatectomy and administration of branched chain amino acids on regional norepinephrine, dopamine, and amino acids in rat brain. Ann Surg 198:172
Jeppsson B, Freund HR, Gimmon Z, James JH, von Meyenfeldt MF, Fischer JE (1982) Blood-brain barrier derangement in uremic encephalopathy. Surgery 92:30
Freund HR, Muggia-Sullam M, Melamed E, LaFrance R, Holroyde J, Fischer JE (1984) Septic encephalopathy. In: Kleinberger G, Ferenci P, Riederer P, Thaler H (eds) Advances in hepatic encephalopathy and urea cycle diseases. Karger, Basel, p 473
Fischer JE, Horst WD, Kopin IJ (1965) Beta-hydroxylated sympathomimetic amines as false neurotransmitters. Br J Pharmacol 24:477
Nespoli A, Bevilcqua G, Staudacher G, Rossi N, Salerno F, Castelli MR (1981) The role of false neurotransmitters in the pathogenesis of hepatic encephalopathy and hyperdynamic syndrome in cirrhosis. Arch Surg 116:1129
Cerra FB, Cheung NK, Fischer JE, Kaplowitz N, Schiff ER, Dienstag JL, Bower RH, Mabry CD, Leery CM, Kiernan T (1985) Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial. JPEN 9:288
Ross-Fanelli F, Cangiano C, Cascino A, Merli M, Riggio O, Stortoni M, Capocaccia L (1984) Branched chain amino acids in the treatment of severe hepatic encephalopathy. In: Capocaccia L, Fischer JE, Rossi-Fanelli F (eds) Hepatic encephalopathy in chronic liver failure. Plenum, New York, p 335
Fiaccadori F, Ghinelli F, Pedretti G, Pelosi G, Sacchini D, Zeneroli ML, Rocchi E, Gibertini P, Ventura E (1984) Branched chain amino acid enriched solutions in the treatment of hepatic encephalopathy. In: Capocaccia L, Fischer JE, Rossi-Fanelli F (eds) Hepatic encephalopathy in chronic liver failure. Plenum, New York, p 323
Strauss E, Santos WR, DaSilva EC, Lacet CM, Capacci MLL, Bernardini AP (1983) A randomized, controlled clinical trial for the evaluation of the efficacy of an enriched branched chain amino acid solution compared to neomycin in hepatic encephalopathy. Hepatology 3:863 (Abstract)
Gluud C, Dejgaard A, Hardt F, Kristensen M, Kohler O, Melgaard B, Schütten HJ, Vilstrup H, Copenhagen Coma Group (1983) Preliminary treatment results with balanced amino acid infusion to patients with hepatic encephalopathy. Scand J Gastroent 18 (Suppl 16):19 (Abstract)
Smith AR, Rossi-Fanelli F, Ziparo V, James JH, Perelle BA, Fischer JE (1978) Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann Surg 187:343
Cerra FB, Mazuski JE, Chule E, Nuwer N, Teasley K, Lysne J, Shronts EP, Konstantinides FN (1984) Branched chain metabolic support: a prospective, randomized, double-blind trial in surgical stress. Ann Surg 199:286
Bower RH, Muggia-Sullam M, Vallgren S, Hurst JM, Kern KA, LaFrance R, Fischer JE (1986) Branched chain amino acid-enriched solutions in the septic patient: a randomized, prospective trial. Ann Surg 203:13
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hasselgren, PO., Fischer, J.E. Septic encephalopathy. Intensive Care Med 12, 13–16 (1986). https://doi.org/10.1007/BF00315361
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315361